Fatal septicemia due to glycopeptide intermediate Staphylococcus aureus [1];Septicémie fatale à Staphylococcus aureus de sensibilité diminuée aux glycopeptides [1]

Annales Francaises d'Anesthesie et de Reanimation

Volumn 20, Issue 5, 2001, Pages 498-499

  Villevieille, T ^a   Vincenti Rouquette, I ^a   Koeck, J L ^a   Petitjeans, F ^a   Rousseau, J M ^a   Brinquin, L ^a  

^a University of Paris Descartes   (France)

Author keywords

Glycopeptides; Staphylococcus aureus

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CIPROFLOXACIN; FLUCONAZOLE; PIPERACILLIN; TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; BETA ADRENERGIC RECEPTOR BLOCKING; CASE REPORT; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; SEPTICEMIA; STAPHYLOCOCCUS AUREUS;

EID: 0034976153     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(01)00402-6     Document Type: Letter

References (6)

1. Update: Staphylococcus aureus with reduced susceptibility to vancomycin- United States, 1997
2. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
3. Structural and topological differences between a glycopeptide-intermediate clinical strain and glycopeptide-susceptible strains of Staphylococcus aureus revealed by atomic force microscopy
4. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
5. Detection of staphylococci with reduced susceptibility to vancomycin using zone diameter and minimal inhibitory concentration criteria
6. Impact de la résistance à la méticilline sur la mortalité liée aux bactériémies à Staphylococcus aureus